BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/28/2026 3:15:33 AM | Browse: 4 | Download: 0
| Category |
Toxicology |
| Manuscript Type |
Basic Study |
| Article Title |
Study on the role of CCM3 in neurological damage in lead exposure of diabetes
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xu Liang, Liu-Xue Yang, Tao Tao, Wen-Jia Ding, Xin-Yi Tang, Zhi-Bin Shang, Hang Zhou, Yun He and Yi Sun |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82060586 |
| Natural Science Foundation of Guangxi Province |
2023GXNSFAA026122, 2020GXNSFAA238036 |
| National Guangxi College Students Innovation and Entrepreneurship Training Program |
S202410601154, S202410601162 and X202410601236 |
| China Scholarship Council |
202208455012 |
|
| Corresponding Author |
Yi Sun, Department of Toxicology, Guilin Medical University, No. 1 Zhiyuan Road, Lingui District, Guilin 541199, Guangxi Zhuang Autonomous Region, China. sunyide163@163.com |
| Key Words |
CCM3; Lead; Diabetes; PI3K-AKT; Ferroptosis |
| Core Tip |
Using a diabetic, CCM3-deficient mouse model with lead exposure, this study demonstrates that lead exposure, diabetes, and CCM3 loss synergistically increase blood glucose and lead levels, resulting in neural injury that precedes vascular damage. Lead triggers early neural impairment by inhibiting the PI3K-AKT signaling pathway and promoting ferroptosis, a mechanism distinct from glucose-related effects. Epidemiological analyses further confirm that interactions among urinary lead levels, blood glucose, and the CCM3 single-nucleoyide polymorphisms rs6784267 significantly influence the neurotransmitter metabolites vanillylmandelic acid and homovanillic acid, consistent with animal findings. Collectively, these results provide a scientific basis for the prevention early neural damage involving environmental, metabolic, and genetic factors. |
| Citation |
Liang X, Yang LX, Tao T, Ding WJ, Tang XY, Shang ZB, Zhou H, He Y, Sun Y. Study on the role of CCM3 in neurological damage in lead exposure of diabetes. World J Diabetes 2026; In press |
 |
Received |
|
2025-09-07 06:46 |
 |
Peer-Review Started |
|
2025-09-08 00:06 |
 |
First Decision by Editorial Office Director |
|
2025-10-22 08:49 |
 |
Return for Revision |
|
2025-10-22 08:49 |
 |
Revised |
|
2025-11-15 03:24 |
 |
Publication Fee Transferred |
|
2025-11-23 03:20 |
 |
Second Decision by Editor |
|
2026-05-28 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-05-28 03:15 |
 |
Articles in Press |
|
2026-05-28 03:15 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-9358 (online) |
| Open Access |
Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.